Abstract.
Objective and design: To examine the effect of leflunomide (LEF) on T cell activation-induced inflammatory cytokine production in human peripheral blood mononuclear cells (PBMC) and rat established adjuvant-induced arthritis (AIA), and compare these effects with methotrexate (MTX) and FK506 (tacrolimus), focusing on improvement of joint function in AIA.
Methods: Human PBMC were cultured with immobilized anti-CD3/CD28 monoclonal antibody to produce tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6. The active metabolite of LEF was used in in vitro study. AIA was induced in female Lewis rats. Paw swelling and grip strength were measured as indicators of arthritis and joint function, respectively. Rats were therapeutically administered LEF (3.2–32 mg/kg) from days 15–24 by oral administration.
Results: LEF inhibited anti-CD3/CD28 induced production of TNF-α, IL-1β and IL-6, with IC50 values of 27, 21 and 21 μg/ml, respectively. LEF also suppressed mouse bone marrow cell MTT conversion, with an IC50 value of 15 μg/ml. LEF significantly inhibited paw swelling and loss of grip strength in established AIA at 10 and 32 mg/kg. The inhibition of paw swelling and grip strength loss by LEF was more potent than MTX. However, maximum recovery of grip strength loss by LEF (23.5%) was less potent compared to that with FK506 (57.8%).
Conclusions: LEF inhibited anti-CD3/CD28 induced inflammatory cytokine production in human PBMC at concentrations showing deleterious effects on bone marrow cell proliferation. LEF is superior to MXT in improving arthritis and joint function in established AIA, but is inferior to FK506 in recovering joint function, probably due to its anti-proliferative actions.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 27 October 2003; returned for revision 22 January 2004; accepted by W. B. van den Berg 10 May 2004
Rights and permissions
About this article
Cite this article
Magari, K., Miyata, S., Nishigaki, F. et al. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: Effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis. Inflamm. res. 53, 544–550 (2004). https://doi.org/10.1007/s00011-004-1294-9
Issue Date:
DOI: https://doi.org/10.1007/s00011-004-1294-9